Biogen BIIB
NASDAQ BIIB
$253.84 +12.86 (+5.34%)
At close: Oct 22, 2026 · 4:00 PM EDT

Biogen (BIIB) Change in Other Operating Liabilities (2009 - 2011)

Updated

Analysis

Biogen (BIIB) Change in Other Operating Liabilities (2009 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.69 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -112.00 Mn
10 Biogen 37.51 Bn 24.16 Bn 1.96 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 -16.56 Mn
Sep 30, 2011 32.11 Mn
Jun 30, 2011 -90.23 Mn
Mar 31, 2011 38.44 Mn
Dec 31, 2010 -23.87 Mn
Sep 30, 2010 708,000.00
Jun 30, 2010 2.81 Mn
Mar 31, 2010 38.04 Mn
Dec 31, 2009 -84.03 Mn
Sep 30, 2009 -19.96 Mn
Jun 30, 2009 -152.12 Mn
Mar 31, 2009 61.38 Mn
API Access

Biogen Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=BIIB&period=max&api_key=YOUR_API_KEY